These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
536 related items for PubMed ID: 109457
1. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women. Lachelin GC, Yen SS. J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457 [Abstract] [Full Text] [Related]
3. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Scott JZ, Kletzky OA, Brenner PF, Mishell DR. Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356 [Abstract] [Full Text] [Related]
10. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation. Jones GE, Wentz AC, Rosenwaks Z, Shoemaker J. Am J Obstet Gynecol; 1977 Dec 01; 129(7):760-76. PubMed ID: 343592 [Abstract] [Full Text] [Related]
11. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men. Wang CF, Lasley BL, Yen SS. J Clin Endocrinol Metab; 1975 Jul 01; 41(1):41-3. PubMed ID: 1097463 [Abstract] [Full Text] [Related]
12. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol. Carlström K, Lunell NO, Zador G. Gynecol Obstet Invest; 1978 Jul 01; 9(6):304-11. PubMed ID: 754992 [Abstract] [Full Text] [Related]
14. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW, de la Peña A, Chenault CB, Cervantes A. Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928 [Abstract] [Full Text] [Related]
16. Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women. Faure N, Labrie F, Olivier G, Tremblay M, Cloutier D, Lemay A, Ferland L, Azadian-Boulanger G, Bouton MM, Husson JM, Raynaud JP. Maturitas; 1980 Jul 01; 2(2):155-68. PubMed ID: 6782429 [Abstract] [Full Text] [Related]
17. The effect of ovarian steroid feedback upon radioimmunoreactive luteinizing hormone releasing hormone in the hypothalamus. Yanaihara T, Arai K, Kanazawa M, Okinaga S, Yanaihara N, Yanaihara C. Endocrinol Jpn; 1975 Dec 01; 22(6):525-30. PubMed ID: 782859 [Abstract] [Full Text] [Related]
18. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive. Spellacy WN, Kalra PS, Buhi WC, Birk SA. Am J Obstet Gynecol; 1980 May 01; 137(1):109-15. PubMed ID: 6768295 [Abstract] [Full Text] [Related]
19. Action of luteinizing hormone-releasing factor (lrf) in the initiation of lordosis behavior in the estrone-primed ovariectomized female rat. Moss RL, McCann SM. Neuroendocrinology; 1975 May 01; 17(4):309-18. PubMed ID: 806824 [Abstract] [Full Text] [Related]
20. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. van Heusden AM, Fauser BC. Contraception; 1999 Apr 01; 59(4):237-43. PubMed ID: 10457868 [Abstract] [Full Text] [Related] Page: [Next] [New Search]